Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium: A model for phage therapy of intracellular bacterial pathogens

Lawrence Broxmeyer, Danuta Sosnowska, Elizabeth Miltner, Ofelia Chacón, Dirk Wagner, Jeffery McGarvey, Raul G Barletta, Luiz E. Bermudez

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Mycobacterium avium causes disseminated infection in patients with acquired immune deficieny syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages. These results suggest a potentially novel concept to kill intracellular pathogenic bacteria and warrant future development.

Original languageEnglish (US)
Pages (from-to)1155-1160
Number of pages6
JournalJournal of Infectious Diseases
Volume186
Issue number8
DOIs
StatePublished - Oct 15 2002

Fingerprint

Mycobacteriophages
Mycobacterium avium
Mycobacterium
Mycobacterium smegmatis
Mycobacterium tuberculosis
Macrophages
Vacuoles
Drug Resistance
Bacteriophages
Bacillus
Anti-Bacterial Agents
Bacteria
Phage Therapy
Therapeutics
Infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium : A model for phage therapy of intracellular bacterial pathogens. / Broxmeyer, Lawrence; Sosnowska, Danuta; Miltner, Elizabeth; Chacón, Ofelia; Wagner, Dirk; McGarvey, Jeffery; Barletta, Raul G; Bermudez, Luiz E.

In: Journal of Infectious Diseases, Vol. 186, No. 8, 15.10.2002, p. 1155-1160.

Research output: Contribution to journalArticle

Broxmeyer, Lawrence ; Sosnowska, Danuta ; Miltner, Elizabeth ; Chacón, Ofelia ; Wagner, Dirk ; McGarvey, Jeffery ; Barletta, Raul G ; Bermudez, Luiz E. / Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium : A model for phage therapy of intracellular bacterial pathogens. In: Journal of Infectious Diseases. 2002 ; Vol. 186, No. 8. pp. 1155-1160.
@article{201adb6c7485495eb61478a25132d867,
title = "Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium: A model for phage therapy of intracellular bacterial pathogens",
abstract = "Mycobacterium avium causes disseminated infection in patients with acquired immune deficieny syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages. These results suggest a potentially novel concept to kill intracellular pathogenic bacteria and warrant future development.",
author = "Lawrence Broxmeyer and Danuta Sosnowska and Elizabeth Miltner and Ofelia Chac{\'o}n and Dirk Wagner and Jeffery McGarvey and Barletta, {Raul G} and Bermudez, {Luiz E.}",
year = "2002",
month = "10",
day = "15",
doi = "10.1086/343812",
language = "English (US)",
volume = "186",
pages = "1155--1160",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent Mycobacterium

T2 - A model for phage therapy of intracellular bacterial pathogens

AU - Broxmeyer, Lawrence

AU - Sosnowska, Danuta

AU - Miltner, Elizabeth

AU - Chacón, Ofelia

AU - Wagner, Dirk

AU - McGarvey, Jeffery

AU - Barletta, Raul G

AU - Bermudez, Luiz E.

PY - 2002/10/15

Y1 - 2002/10/15

N2 - Mycobacterium avium causes disseminated infection in patients with acquired immune deficieny syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages. These results suggest a potentially novel concept to kill intracellular pathogenic bacteria and warrant future development.

AB - Mycobacterium avium causes disseminated infection in patients with acquired immune deficieny syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages. These results suggest a potentially novel concept to kill intracellular pathogenic bacteria and warrant future development.

UR - http://www.scopus.com/inward/record.url?scp=0037108928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037108928&partnerID=8YFLogxK

U2 - 10.1086/343812

DO - 10.1086/343812

M3 - Article

C2 - 12355367

AN - SCOPUS:0037108928

VL - 186

SP - 1155

EP - 1160

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 8

ER -